Esperion Therapeutics, Inc. SEC Filings

Filed On	Filing
13 Aug 2026	SCHEDULE 13G
31 Jul 2026	SCHEDULE 13G
23 Jul 2026	FORM 15-12G
15 Jul 2026	EFFECT
15 Jul 2026	EFFECT
15 Jul 2026	EFFECT
15 Jul 2026	EFFECT
15 Jul 2026	EFFECT
15 Jul 2026	EFFECT
14 Jul 2026	SCHEDULE 13G/A
13 Jul 2026	Form 4: Hoffman Robert E., Director Returned 85,153 shares to the issuer · Disposed of 47,040 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Carroll J Martin, Director Returned 177,523 shares to the issuer · Disposed of 97,500 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Shepard Jay, Director Returned 164,472 shares to the issuer · Disposed of 97,500 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Fischer Seth H. Z., Director Returned 141,023 shares to the issuer · Disposed of 97,500 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Thompson John Craig, Director Returned 79,873 shares to the issuer · Disposed of 40,000 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Harlow John B. Jr., Chief Commercial Officer Returned 424,536 shares to the issuer
13 Jul 2026	Form 4: Looker Benjamin, Chief Legal Officer Returned 667,524 shares to the issuer · Disposed of 620,230 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Halladay Benjamin, Chief Financial Officer Returned 705,410 shares to the issuer · Disposed of 634,270 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Koenig Sheldon L., Director Returned 2,121,094 shares to the issuer · Disposed of 1,289,460 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 753,000 Stock Option (right to buy (Disposition to Issuer)
13 Jul 2026	POSASR

Comments